Page 1 of Clinical Trials for Non-Metastatic Prostate Cancer, 60 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Last Updated: June 24, 2011
Condition(s): Prostate Cancer
2
Completed
Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer
Last Updated: April 22, 2009
Condition(s): Non-Metastatic Prostate Cancer
3
Recruiting
A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
Last Updated: March 16, 2011
Condition(s): Non-metastatic Prostate Cancer; Post Radical Prostatectomy
4
Active, not recruiting
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Last Updated: December 3, 2009
Condition(s): Prostate Cancer
5
Active, not recruiting
An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
Last Updated: August 25, 2011
Condition(s): Cancer; Carcinoma; Castrate-Resistant Prostate Cancer; Prostate Cancer; Tumors
6
Recruiting
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Last Updated: March 30, 2012
Condition(s): Cancer; Cataract; Low Bone Mineral Density; Osteopenia; Osteoporosis; Prostate Cancer
7
Not yet recruiting
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Last Updated: November 1, 2009
Condition(s): Prostate Cancer
8
Completed
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
Last Updated: May 9, 2011
Condition(s): Prostate Cancer
9
Recruiting
Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer
Last Updated: February 10, 2012
Condition(s): Prostate Cancer
10
Completed
(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
Last Updated: December 9, 2010
Condition(s): Non-Metastatic Prostate Cancer
11
Completed
Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
Last Updated: May 26, 2009
Condition(s): Non-Metastatic Prostate Cancer
12
Recruiting
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Last Updated: May 3, 2012
Condition(s): Prostatic Neoplasm; Prostate Cancer; Prostatic Adenocarcinoma
13
Suspended
Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
14
Recruiting
Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
15
Active, not recruiting
Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
Last Updated: October 26, 2011
Condition(s): Prostate Cancer
16
Active, not recruiting
Sildenafil Citrate and Alprostadil in Treating Patients Undergoing Bilateral Nerve-Sparing Robotic-Assisted Prostatectomy for Nonmetastatic Prostate Cancer
Last Updated: September 20, 2011
Condition(s): Prostate Cancer; Male Erectile Disorder; Stage I Prostate Cancer; Stage II Prostate Cancer
17
Completed
Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
Last Updated: September 2, 2011
Condition(s): Prostate Cancer
18
Active, not recruiting
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Last Updated: February 18, 2011
Condition(s): Osteoporosis; Prostate Cancer
19
Completed
Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Last Updated: March 10, 2009
Condition(s): Non-Metastatic Prostate Cancer
20
Completed
Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
Last Updated: December 22, 2008
Condition(s): Prostatic Neoplasm

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Non-Metastatic+Prostate+Cancer

Page 1 of Clinical Trials for Non-Metastatic Prostate Cancer, 60 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About